Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

ReWalk Robotics Ltd. - Ordinary Shares (NQ: LFWD )

4.659 -0.091 (-1.92%)
Streaming Delayed Price Updated: 2:06 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,443
Open 4.840
Bid (Size) 4.610 (1)
Ask (Size) 4.710 (1)
Prev. Close 4.750
Today's Range 4.610 - 4.840
52wk Range 0.5900 - 6.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lifeward Announces the Appointment of Mike Swinford to its Board of Directors
Experienced healthcare and rehabilitation technology professional brings more than 30 years of experience in commercialization and new business development 
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton
Finalized Medicare reimbursement pathway for personal exoskeletons expands access for all eligible Medicare beneficiaries 
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire

Performance

YTD
+335.38%
+335.38%
1 Month
-8.30%
-8.30%
3 Month
+361.25%
+361.25%
6 Month
+335.38%
+335.38%
1 Year
+335.38%
+335.38%

More News

Read More
Unleashing the Underdogs: 3 Hidden Gems Set to Conquer the Market
Via InvestorPlace
Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Announces Reverse Share Split
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
ReWalk Robotics Q4 Earnings Miss Estimates, Issues FY24 Guidance
Via Benzinga
Topics Earnings
Exposures Financial
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.